Seeking Alpha

Mylan (MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality...

Mylan (MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6B in cash. The acquisition significantly expands MYL's global injectables platform and will provide entry into new high-growth geographic markets. The acquisition is expected to close in Q4 of 2013 should be immediately accretive to earnings. Shares +1.8% AH.
Comments (1)
  • Fogbound
    , contributor
    Comments (11) | Send Message
     
    This should be a big help in the expansion of the EpiPen market.
    28 Feb 2013, 04:41 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector